跳至主要内容
临床试验/NL-OMON29546
NL-OMON29546尚未招募不适用

DISCOntinuation VERsus continuation of antiarrhythmic drugs prior to Pulmonary Vein Isolation for atrial fibrillation and influence on dormant conduction with adenosine; a randomised controlled trial.

MST Enschede0 个研究点目标入组 188 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
188

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Adults with atrial fibrillation EHRA class II or higher during therapy with class I or III (excluding amiodaron) antiarrhythmic drugs eligible for PVI.

排除标准

  • -Usage of amiodaron (due to very long half life time(20-100 days) these patients will be excluded)
  • -Prior PVI or MAZE

研究者

发起方
MST Enschede

相似试验

DISCOntinuation VERsus continuation of... | 临床试验